Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-04-05-Speech-2-463-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110405.21.2-463-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"What I can say in general is that we have to address all these problems bearing in mind that what we have here is a competence of the Member States. So we have to respect that.
I can understand your point that discrepancies persist but the Commission will nevertheless do everything it can to facilitate Member States in harmonising the situation between them. Our priority is to facilitate cooperation among Member States to reduce the inequalities. Another thing we can do is to pursue the issue as part of the Process on Corporate Responsibility in the field of Pharmaceuticals launched by the Commission.
On the question raised by Mr Chountis, what I can say is that when the directive is in place we will provide a clear legal framework regarding rights to reimbursement for cross-border health care. We then propose to reduce the inequalities inherent in divergent implementation of European court decisions. Citizens will then be sure about when and on what basis they will, or will not, be reimbursed for care received abroad. Until then we have to wait, I’m afraid."@en1
|
| lpv:unclassifiedMetadata | |
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples